Correlation Between ARCA Biopharma and OncoSec Medical
Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and OncoSec Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and OncoSec Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ARCA Biopharma and OncoSec Medical, you can compare the effects of market volatilities on ARCA Biopharma and OncoSec Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of OncoSec Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and OncoSec Medical.
Diversification Opportunities for ARCA Biopharma and OncoSec Medical
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ARCA and OncoSec is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and OncoSec Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoSec Medical and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with OncoSec Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoSec Medical has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and OncoSec Medical go up and down completely randomly.
Pair Corralation between ARCA Biopharma and OncoSec Medical
Given the investment horizon of 90 days ARCA Biopharma is expected to generate 0.62 times more return on investment than OncoSec Medical. However, ARCA Biopharma is 1.62 times less risky than OncoSec Medical. It trades about -0.02 of its potential returns per unit of risk. OncoSec Medical is currently generating about -0.29 per unit of risk. If you would invest 1,309 in ARCA Biopharma on August 31, 2024 and sell it today you would lose (1,309) from holding ARCA Biopharma or give up 100.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 10.29% |
| Values | Daily Returns |
ARCA Biopharma vs. OncoSec Medical
Performance |
| Timeline |
| ARCA Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| OncoSec Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ARCA Biopharma and OncoSec Medical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ARCA Biopharma and OncoSec Medical
The main advantage of trading using opposite ARCA Biopharma and OncoSec Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, OncoSec Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoSec Medical will offset losses from the drop in OncoSec Medical's long position.| ARCA Biopharma vs. Aerovate Therapeutics | ARCA Biopharma vs. Adagene | ARCA Biopharma vs. Acrivon Therapeutics, Common | ARCA Biopharma vs. Rezolute |
| OncoSec Medical vs. ZyVersa Therapeutics | OncoSec Medical vs. Palisade Bio | OncoSec Medical vs. Unicycive Therapeutics | OncoSec Medical vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |